The authorities on the French overseas territory of Réunion Island have issued a health alert after more than 4,000 new cases ...
Shares of Valneva SE (NASDAQ:VALN – Get Free Report) gapped down before the market opened on Tuesday after Guggenheim lowered their price target on the stock from $17.00 to $15.00. The stock had ...
Valneva responds to French govt’s call for supply of chikungunya vaccine, Ixchiq: Saint Herblain, France Wednesday, March 26, 2025, 17:00 Hrs [IST] Valneva SE, a specialty vacci ...
Valneva (NASDAQ:VALN – Get Free Report) had its target price dropped by research analysts at Guggenheim from $17.00 to $15.00 in a research note issued to investors on Monday,Benzinga reports. The ...
SE announced earlier that it is responding to the chikungunya outbreak that is rapidly intensifying in France’s Island of La ...
Thousands have been infected and two have been killed by the debilitating, mosquito-borne virus in the space of a few weeks ...
Valneva will work with local health authorities and wholesalers on the French island territory to distribute the vaccines.
Chikungunya cases have spiked substantially in La Réunion since early 2025, with 8,600 cases recorded and almost 3,000 new cases during the week of March 3 to 9, 2025 1. Similar to the 2005-2006 ...
Valneva anticipates total product sales of €170 million to €180 million and total revenues of €180 million to €190 million for 2025, driven by increased IXCHIQ sales and growth in IXIARO and DUKORAL.
1 Valneva Receives Marketing Authorization in Europe for the World’s First Chikungunya Vaccine, IXCHIQ® 2 Valneva Reports Further Positive Pivotal Phase 3 Data in Adolescents for its Single ...
NEW YORK, March 4, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Valneva SE ... vaccination with IXCHIQ [Valneva's chikungunya virus vaccine] among people ...
Pomerantz LLP is investigating claims on behalf of investors of Valneva SE ("Valneva" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ...